X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE J.B.CHEMICALS SUVEN LIFE/
J.B.CHEMICALS
 
P/E (TTM) x 20.2 18.1 111.4% View Chart
P/BV x 4.4 2.5 179.8% View Chart
Dividend Yield % 0.5 0.2 327.7%  

Financials

 SUVEN LIFE   J.B.CHEMICALS
EQUITY SHARE DATA
    SUVEN LIFE
Mar-18
J.B.CHEMICALS
Mar-16
SUVEN LIFE/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs251318 78.8%   
Low Rs155200 77.7%   
Sales per share (Unadj.) Rs49.1148.0 33.2%  
Earnings per share (Unadj.) Rs9.719.1 50.9%  
Cash flow per share (Unadj.) Rs11.423.9 47.6%  
Dividends per share (Unadj.) Rs1.500.50 300.0%  
Dividend yield (eoy) %0.70.2 382.7%  
Book value per share (Unadj.) Rs60.3128.9 46.8%  
Shares outstanding (eoy) m127.2884.82 150.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.11.7 236.2%   
Avg P/E ratio x20.913.6 154.0%  
P/CF ratio (eoy) x17.810.8 164.8%  
Price / Book Value ratio x3.42.0 167.7%  
Dividend payout %15.42.6 589.2%   
Avg Mkt Cap Rs m25,82521,951 117.6%   
No. of employees `0001.12.7 39.2%   
Total wages/salary Rs m6131,841 33.3%   
Avg. sales/employee Rs Th5,832.64,590.9 127.0%   
Avg. wages/employee Rs Th571.5673.4 84.9%   
Avg. net profit/employee Rs Th1,153.8592.1 194.9%   
INCOME DATA
Net Sales Rs m6,25312,551 49.8%  
Other income Rs m233542 43.0%   
Total revenues Rs m6,48513,093 49.5%   
Gross profit Rs m1,9822,055 96.5%  
Depreciation Rs m213412 51.7%   
Interest Rs m4696 48.4%   
Profit before tax Rs m1,9552,088 93.6%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718469 153.1%   
Profit after tax Rs m1,2371,619 76.4%  
Gross profit margin %31.716.4 193.6%  
Effective tax rate %36.722.5 163.5%   
Net profit margin %19.812.9 153.4%  
BALANCE SHEET DATA
Current assets Rs m5,6227,778 72.3%   
Current liabilities Rs m1,1684,358 26.8%   
Net working cap to sales %71.227.2 261.5%  
Current ratio x4.81.8 269.8%  
Inventory Days Days8155 148.9%  
Debtors Days Days3680 44.9%  
Net fixed assets Rs m3,3255,713 58.2%   
Share capital Rs m127170 75.1%   
"Free" reserves Rs m7,54710,547 71.6%   
Net worth Rs m7,67410,937 70.2%   
Long term debt Rs m140-   
Total assets Rs m9,13515,574 58.7%  
Interest coverage x43.222.8 189.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.8 84.9%   
Return on assets %14.011.0 127.6%  
Return on equity %16.114.8 108.9%  
Return on capital %26.020.0 130.4%  
Exports to sales %048.7 0.0%   
Imports to sales %07.1 0.0%   
Exports (fob) Rs mNA6,115 0.0%   
Imports (cif) Rs mNA889 0.0%   
Fx inflow Rs m5,0666,169 82.1%   
Fx outflow Rs m2,0011,285 155.7%   
Net fx Rs m3,0654,884 62.8%   
CASH FLOW
From Operations Rs m6991,397 50.1%  
From Investments Rs m-6-320 1.9%  
From Financial Activity Rs m-577-1,196 48.3%  
Net Cashflow Rs m116-102 -113.7%  

Share Holding

Indian Promoters % 63.4 55.4 114.4%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 0.0 3.4 -  
FIIs % 0.0 3.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 37.0 98.6%  
Shareholders   37,287 30,437 122.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   DIVIS LABORATORIES  WOCKHARDT LTD.  SUN PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 170 Points Lower, Realty and FMCG Stocks Witness Selling(Closing)

After opening the day on a positive note, share markets in India witnessed volatile trading activity and ended in red.

Related Views on News

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

SUVEN LIFE Announces Quarterly Results (4QFY18); Net Profit Up 56.0% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, SUVEN LIFE has posted a net profit of Rs 625 m (up 56.0% YoY). Sales on the other hand came in at Rs 2 bn (up 18.6% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

Should You Be Worried About the Rising Dollar?(Chart Of The Day)

Sep 7, 2018

While the rupee has deprecated by about 5% annually since 1990 against the dollar, the BSE Sensex has returned 14% annually in the same period.

Revenge of the Ratings Agencies(Vivek Kaul's Diary)

Sep 7, 2018

Do you remember when ratings agencies ruled financial markets? Nick explains why he thinks it's time to prepare yourselves for a comeback of the ratings agencies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Sep 19, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS